[Mechanism of action of calcium antagonists in the treatment of vascular diseases].
The therapeutic effect of selective calcium entry blockers in the treatment of chronic occlusive diseases of peripheral and cerebral arteries is well documented. Experimental studies in acute cerebral ischaemia and cerebral infarction allow to anticipate positive results in clinical studies. The number of clinical studies so far available is to small for final assessment at the present time.
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D005444:Flunarizine / Q000627:therapeutic use; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D008881:Migraine Disorders / Q000188:drug therapy; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009543:Nifedipine / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D007473:Ion Channels; D009543:Nifedipine; D005444:Flunarizine; D002118:Calcium
Zur Wirkungsweise von Kalziumantagonisten in der Behandlung von Gefässerkrankungen.